Latest News

ToxStrategies is pleased to announce that we are partnering with Feeding America to help provide food to the millions of Americans currently in need. Feeding America targets areas with the greatest need to ensure that funds reach the most vulnerable among us. Feeding America collects data from food banks, along with the number of COVID cases and unemployment rates, to disburse these funds appropriately.   Feeding America projects that the pandemic could result in an estimated additional 17.1 read more…

ToxStrategies scientists have developed a range of plausible toxicity values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on application of systematic review methods and quantitative integration of dose response using meta-regression. This research is being published in the journal Toxicological Sciences and will advance risk assessments involving this class of compounds, providing important information to guide risk-based decision-making.

  ToxStrategies is excited to be participating in the Society for Risk Analysis (SRA)’s 2020 Annual Meeting, which will be held virtually December 13-17th. We have two virtual poster presentations this year.    Camarie Perry, William Rish, Liz Mittal and Mark Harris have a virtual poster during the Food Exposure Assessment session from 1:30 to 3 pm CST on December 14th. Camarie Perry will present the poster.   The poster is titled, “Use of probabilistic risk assessment and physiologically based pharmacokinetic modeling in supporting soil remedial objectives for dioxins and furans at a read more…

EpidStrategies is excited to be participating in the American Society of Hematology (ASH) Annual Meeting, which will be held virtually on December 5-8, 2020.  Xiaohui Jiang will have a virtual poster during the American Society of Hematology (ASH) annual meeting on Saturday, December 5, 2020. Their presentation of the poster will be available from 7:30 am–3:30 pm PST.   The poster is titled, “Medically attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease (CAD).”   This year’s ASH read more…

ToxStrategies scientists Dr. Mark Harris, Dr. Deborah Proctor, and Dr. Chad Thompson are among the authors of a recently published study that proposes a cytotoxicity-mediated adverse outcome pathway (AOP) for small intestinal tumors by leveraging extensive target species- and site-specific molecular, cellular, and histological mode of action research for three reference chemicals, the fungicides captan and folpet and the transition metal hexavalent chromium. This AOP supports that duodenal tumors in mice occur secondary to chronic villous enterocyte cytotoxicity and regenerative repair-driven proliferation.   This read more…

ToxStrategies is pleased to announce that Dr. Kristina Ulrich has joined our Biopharmaceuticals and Pharmaceuticals practice. Dr. Ulrich is a European Registered Toxicologist (ERT) and a former nonclinical assessor at the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. She brings 15 years of experience in pharmaceutical development, along with her background and expertise in the European regulatory arena. In the pharmaceutical industry, she has led the nonclinical safety strategy for products in development and read more…

Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian Pharmacists’ Association Women in Pharmacy Leadership Empowerment Panel, sponsored by Amgen. The five-person panel will focus on “Social Capital: Strategic Networking for Women in Leadership” during the event on November 18, 2020, 11:00–12:30 pm ET. There is no charge to those interested in listening in: register here. Dr. Hooda has a clinical and research read more…

ToxStrategies scientist, Dr. Laurie Haws was recently elected to the Board of Directors for The Toxicology Forum. The Toxicology Forum is a leading international toxicology organization that strives to promote open and deliberative dialogue to build understanding among government agencies, industry, academia, policymakers, and public interest groups to shape decision-making and outcomes on critical issues in toxicology and its applications. Dr. Haws will serve a vice president of The Toxicology Forum for the upcoming year. read more…